INTERNATIONAL PATENT: ELUMINEX BIOSCIENCES LIMITED FILES APPLICATION FOR "MULTISPECIFIC FUSION PROTEINS TARGETING ANGIOGENIC, INFLAMMATORY AND/OR FIBROTIC FACTORS"

GENEVA, June 9 -- ELUMINEX BIOSCIENCES LIMITED (Aequitas International Management Ltd., Grand Pavilion Commercial Centre,Suite 24, 802 West Bay Road,P.O. Box 10281,Grand Cayman KYI-1003,) filed a patent application (PCT/CN2023/134829) for "MULTISPECIFIC FUSION PROTEINS TARGETING ANGIOGENIC, INFLAMMATORY, AND/OR FIBROTIC FACTORS" on Nov 28, 2023. With publication no. WO/2025/111816, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SHEN, Wei Yong (18 Grey Street CarltonNew South Wales 2218), ZHANG, Jinzhong (47 Persimmon Wal...